NOTE 6—GOODWILL AND INTANGIBLE ASSETS, NET
Resulting from a change in reportable segments as described in Note 16—Business Segments, the Company reassessed its goodwill reporting units. As a result, certain reporting units were combined. The Company now has four goodwill reporting units: Natural, Conventional and Retail, which are each separate operating and reportable segments; and Woodstock Farms, which does not meet the criteria of an operating segment and is reported within the Natural segment.
In the fourth quarter of fiscal 2025, 2024 and 2023 the Company performed its annual goodwill qualitative impairment review and determined that a quantitative impairment test was not required for any of its reporting units.
Goodwill and Intangible Assets Changes
The Company’s Goodwill balance as of August 2, 2025 and August 3, 2024 was $19 million, net of accumulated goodwill impairment charges of $727 million, and was only attributable to the Natural reporting unit. There were no goodwill impairment charges during fiscal 2025, 2024 or 2023. Changes in the carrying value of Goodwill for fiscal 2025 and fiscal 2024 were due to changes in foreign exchange rates.
Identifiable intangible assets, net consisted of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2025 | | 2024 |
| (in millions) | Gross Carrying Amount | | Accumulated Amortization | | Net | | Gross Carrying Amount | | Accumulated Amortization | | Net |
| Amortizing intangible assets: | | | | | | | | | | | |
| Customer relationships | $ | 1,007 | | | $ | 472 | | | $ | 535 | | | $ | 1,007 | | | $ | 413 | | | $ | 594 | |
| Pharmacy prescription files | 33 | | | 32 | | | 1 | | | 33 | | | 27 | | | 6 | |
| | | | | | | | | | | |
| Operating lease intangibles | 3 | | | 3 | | | — | | | 6 | | | 5 | | | 1 | |
| Trademarks and tradenames | 85 | | | 70 | | | 15 | | | 88 | | | 65 | | | 23 | |
| Total amortizing intangible assets | 1,128 | | | 577 | | | 551 | | | 1,134 | | | 510 | | | 624 | |
| Indefinite lived intangible assets: | | | | | | | | | | | |
| Trademarks and tradenames | 25 | | | — | | | 25 | | | 25 | | | — | | | 25 | |
| Intangibles assets, net | $ | 1,153 | | | $ | 577 | | | $ | 576 | | | $ | 1,159 | | | $ | 510 | | | $ | 649 | |
The Company performed annual qualitative reviews of its indefinite lived trademarks and tradenames in fiscal 2025 and 2024, which indicated a quantitative assessment was not required.
In the fourth quarter of fiscal 2023, the Company decided to rationalize certain of its brands within its Blue Marble Brands portfolio, resulting in an abandonment of certain brands and a shortened life of remaining brand-related intangible assets. These changes were part of an effort for the Company to focus on its core private brand offerings. As a result, the Company recorded a $25 million intangible asset impairment charge in fiscal 2023 and began amortizing the remaining intangible assets associated with its Blue Marble Brands portfolio. The fair values utilized in the Company’s quantitative assessment were determined using the income approach, discounting projected future net cash flows based on management’s expectations of the current and future operating environment for each brand. The impairment charge is recorded within Loss on sale of assets and other asset charges in the Consolidated Statements of Operations.
Amortization expense was $71 million, $72 million and $72 million for fiscal 2025, 2024 and 2023, respectively. The estimated future amortization expense for each of the next five fiscal years and thereafter on amortizing intangible assets existing as of August 2, 2025 is as shown below:
| | | | | |
| Fiscal Year: | (in millions) |
| 2026 | $ | 66 | |
| 2027 | 63 | |
| 2028 | 61 | |
| 2029 | 51 | |
| 2030 | 48 | |
| Thereafter | 262 | |
| $ | 551 | |